Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/30/2025

Concurrent Marijuana and Sertraline Use

Adverse Effects of SSRI

  • Common SSRI adverse effects include nausea, diarrhea, dizziness, headache, insomnia, sexual dysfunction, and somnolence, according to the American College of Physicians, as reported in the Annals of Internal Medicine 1
  • Serious but rare complications of SSRI use include serotonin syndrome, which is typically associated with concomitant use of multiple serotonergic drugs, as noted by the American Urological Association 2, 3

Pharmacokinetics and Drug Interactions

  • Sertraline has minimal effects on major cytochrome P450 enzymes and fewer drug-drug interactions compared to other SSRIs, as reported by the National Institute of Health, although this information is also available from Praxis Medical Insights 4, 5
  • Cannabis can cause cognitive and physical impairment, requiring avoidance of driving or safety-sensitive work for up to 12 hours depending on product type, according to the American Society of Clinical Oncology 6
  • Potential drug interactions exist with certain medications metabolized through specific pathways, but syncope is not specifically identified as a concern with SSRI combinations, as noted by the American Society of Clinical Oncology 6

Clinical Considerations

  • If marijuana causes significant orthostatic hypotension in a particular individual, and sertraline contributes to dizziness, the combination could theoretically predispose to presyncope, according to the American College of Physicians, as reported in the Annals of Internal Medicine 1
  • Serotonin syndrome risk increases with recreational drugs like amphetamines or cocaine combined with SSRIs, though marijuana is not specifically listed as a serotonergic agent, as noted by the American Urological Association 3
  • Individual patient factors such as dehydration, concurrent medications affecting blood pressure, or underlying cardiovascular conditions would be more relevant to syncope risk than this specific drug combination, according to the American College of Physicians, as reported in the Annals of Internal Medicine 1